Sacituzumab,pembrolizumab
merck,gilead
['sacituzumab', 'breast', 'capecitabine', 'pembro', 'ascent', 'tnbc', 'sacitu, govi']
#asco23 #breastcancer poster session:
ascent-05/optimice-rd: phase 3 study of adjuvant sacituzumab govitecan + pembro vs pembro capecitabine in patients with #tnbc and residual disease after neoadjuvant therapy and surgery. 
Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425